PERCLOSE PROGLIDE
Device
Abbott Laboratories
Total Payments
$943,489
Transactions
4,944
Doctors
2,390
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $256,773 | 1,179 | 528 |
| 2023 | $48,036 | 893 | 611 |
| 2022 | $471,136 | 2,864 | 1,524 |
| 2021 | $167,543 | 8 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $517,354 | 85 | 54.8% |
| Food and Beverage | $177,036 | 4,496 | 18.8% |
| Consulting Fee | $118,663 | 23 | 12.6% |
| Travel and Lodging | $114,795 | 322 | 12.2% |
| Debt forgiveness | $7,344 | 5 | 0.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,558 | 8 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,250 | 3 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $483.00 | 1 | 0.1% |
| Education | $6.00 | 1 | 0.0% |
Payments by Type
Research
$517,354
85 transactions
General
$426,135
4,859 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Vascular Closure for Cardiac Ablation Registry (VACCAR) | Abbott Laboratories | $364,890 | 0 |
| Perclose Multi-Access DUS Study | Abbott Laboratories | $122,188 | 0 |
| Perclose Multi Access DUS | Abbott Laboratories | $2,310 | 0 |
Top Doctors Receiving Payments for PERCLOSE PROGLIDE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Atlanta, GA | $525,343 | 102 |
| , MD | Interventional Cardiology | Kansas City, MO | $20,769 | 13 |
| , MD | Interventional Cardiology | Gainesville, FL | $19,310 | 4 |
| , MD | Vascular Surgery | Los Angeles, CA | $17,505 | 22 |
| , MD | Vascular & Interventional Radiology | Pembroke Pines, FL | $16,849 | 15 |
| Christian Bianchi | Surgery | Loma Linda, CA | $13,544 | 2 |
| , M.D | Internal Medicine | New York, NY | $12,231 | 2 |
| , MD | Cardiovascular Disease | Oklahoma City, OK | $11,724 | 7 |
| , MD | Vascular Surgery | Manchester, NH | $5,860 | 9 |
| , M.D | Internal Medicine | Galloway, NJ | $5,000 | 4 |
| , M.D | Specialist | New York, NY | $4,991 | 18 |
| , M.D | Surgery | Detroit, MI | $4,412 | 6 |
| , MD | Internal Medicine | Kansas City, MO | $3,534 | 3 |
| , M.D | Cardiovascular Disease | Austin, TX | $3,438 | 4 |
| , M.D | Internal Medicine | Columbus, OH | $3,300 | 1 |
| , M.D | Internal Medicine | Omaha, NE | $2,529 | 13 |
| , D.O | Internal Medicine | Chattanooga, TN | $2,507 | 12 |
| , M.D | Vascular & Interventional Radiology | Chicago, IL | $2,397 | 15 |
| , M.D | Diagnostic Radiology | Jeffersonville, IN | $2,280 | 13 |
| , M.D | Interventional Cardiology | Powell, TN | $2,244 | 13 |
| , M.D | Cardiovascular Disease | Edison, NJ | $2,224 | 13 |
| , MD | Vascular Surgery | Los Angeles, CA | $2,203 | 17 |
| , MD | Surgery | Philadelphia, PA | $2,168 | 14 |
| , DO | Cardiovascular Disease | Flint, MI | $2,094 | 13 |
| , M.D | Interventional Cardiology | Manhattan, KS | $2,070 | 13 |
Ad
Manufacturing Companies
- Abbott Laboratories $943,489
Product Information
- Type Device
- Total Payments $943,489
- Total Doctors 2,390
- Transactions 4,944
About PERCLOSE PROGLIDE
PERCLOSE PROGLIDE is a device associated with $943,489 in payments to 2,390 healthcare providers, recorded across 4,944 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2021 to 2024. In 2024, $256,773 was paid across 1,179 transactions to 528 doctors.
The most common payment nature for PERCLOSE PROGLIDE is "Unspecified" ($517,354, 54.8% of total).
PERCLOSE PROGLIDE is associated with 3 research studies, including "Vascular Closure for Cardiac Ablation Registry (VACCAR)" ($364,890).